Clinical Trial Update: Retrospective Data Collection Study in Patients With Macular Oedema Receiving OZURDEX®

View source ↗

Summary

Results from a retrospective data collection study of patients with macular edema treated with OZURDEX were posted in May 2015, sponsored by Allergan.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Macular Edema
• Retinal Vein Occlusion

Drugs mentioned

• Ozurdex (dexamethasone intravitreal implant)

Snippet

Sponsor: Allergan | Conditions: Macular Edema, Retinal Vein Occlusion | Status: COMPLETED | Results posted: 2015-05-25